Novo Nordisk Surpasses $500 Billion Mark as Obesity Drug Sales Soar by 154%
The shares of Novo Nordisk rose by 4% on Wednesday, settling at 1.2% higher, placing its market value at around $500 billion. Novo Nordisk, the Danish pharmaceutical giant, has reached…